Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1889 of 5804
-
Lung wash may spot cancer genes without needles
Diagnosis OngoingThis is a single center, clinical trial evaluating the relevance of intratumoral washing for detection of generic alteration with Next Generation Sequencing.
Phase: NA • Sponsor: Pusan National University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Could cutting carbs help pregnant women with diabetes?
Disease control Recruiting nowDiabetes during pregnancy increases maternal and fetal complications, necessitating optimal glycemic control. The standard care diet (SCD, ≥175g/day carbohydrate) lacks robust evidence, particularly for pregnancies requiring intensive insulin treatment (IIT). This RCT investigate…
Phase: NA • Sponsor: Hadassah Medical Organization • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could giving TB pills on day one save more lives?
Disease control CompletedBackground: In 2023, the South African Department of Health introduced targeted universal TB testing (TUTT) at antiretroviral therapy (ART) initiation (irrespective of the presence of TB symptoms). Guidelines regarding TPT initiation in the setting of TUTT are conflicting - recom…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Brain signals may explain impulsive actions in depressed teens
Knowledge-focused Recruiting nowThe goal of this study is to understand why some people act more impulsively when feeling negative emotions, which is called negative urgency. The researchers hope to understand how negative urgency relates to the way networks of brain cells communicate with one another. The rese…
Phase: NA • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New pill combo aims to ease arthritis pain in 60 days
Symptom relief CompletedThe goal of this clinical trial is to learn if fixed-dose combination etoricoxib 90 mg + diacerein 50 mg capsule works to treat knee/hip osteoarthritis-associated pain in adults. It will also learn about the safety of the drug. The main questions it aims to answer are: Does etor…
Phase: PHASE3 • Sponsor: Laboratorios Liomont • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Can a simple air cleaner ease COPD symptoms?
Disease control Recruiting nowThis is a multi-center randomized, sham-controlled clinical trial to determine the effectiveness of an air cleaner intervention aimed at improving indoor air quality on reducing COPD exacerbation risk and improving quality of life, functional status, rescue medication use.
Phase: PHASE3 • Sponsor: JHSPH Center for Clinical Trials • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New scanner aims to spot lung cancer more clearly
Diagnosis Recruiting nowPurpose The aim of the study is to investigate the utilization of photon counting CT (PCCT) and the spectral information provided to determine the impact of spectral information on follow-up examinations. As secondary aims we will compare conventional CT, CT + 18Flouro-deoxy-glu…
Phase: NA • Sponsor: Copenhagen University Hospital at Herlev • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Antiviral drug ganciclovir explored as new weapon against stubborn allergies
Disease control Recruiting nowThe goal of this clinical trial is to learn about the clinical efficacy and safety of ganciclovir (GCV) capsules in the treatment of refractory moderate-to-severe allergic rhinitis. The main questions it aims to answer are: 1. Whether ganciclovir improve nasal symptoms and life …
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Blood cancer drug bomedemstat tested for Long-Term safety
Disease control Recruiting nowThe primary purpose of the study is to transition participants into an extension study to collect long-term safety and efficacy data. The study will include participants who are safely tolerating bomedemstat, receiving clinical benefit from its use in estimation of the investigat…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Village-Wide healthy living program shows promise for lowering blood pressure
Prevention CompletedThis is a 1:1 parallel design, multi-center, cluster-randomized control trial. A total of 80 villages in Ruyang County, Henan Province, China, will be randomly assigned to the intervention group or control group. At least 100 participants from 30-50 families in each village will …
Phase: NA • Sponsor: Heart Health Research Center • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
New mRNA flu shot shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThe purpose of this study is to assess the safety and immune response of GlaxoSmithKlines (GSK) messenger RNA (mRNA)-based multivalent vaccine (GSK4382276A) candidate against influenza, administered in healthy younger adults (YA) and older adults (OA).
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:00 UTC
-
Zapping acne with radio waves: new device tested
Disease control OngoingEvaluation of the safety and efficacy of fractional radiofrequency for the treatment of moderate to severe acne vulgaris.
Phase: NA • Sponsor: Pollogen • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New schizophrenia drug shows promise in reducing symptoms
Symptom relief CompletedThis is a Phase 2b, randomized, double-blind, parallel-group, active-controlled and placebo-controlled, multicenter inpatient study to examine the efficacy and safety of HS-10380 in adult Participants who are acutely psychotic with a Diagnostic and Statistical Manual Fifth Editio…
Phase: PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can mindfulness tame tics? new study tests a Drug-Free approach
Symptom relief Recruiting nowThis research study is being done to compare a mindfulness-based intervention for tics (MBIT) to psychoeducation with relaxation and supportive therapy (PRST) for individuals with Tourette's syndrome or Persistent Tic Disorders (collectively TS). It is the investigator's hope tha…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Could a simple assessment help older lung cancer patients tolerate chemo better?
Symptom relief Recruiting nowThis clinical trial tests how well a geriatric assessment (GA) with GA-directed treatment recommendations, compared to GA with usual care, works in identifying risk factors, reducing chemotherapy radiation toxicity and functional decline, and improving the overall quality of life…
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New lupus drug ianalumab tested for Long-Term safety
Disease control Recruiting nowThe purpose of this study is to evaluate long-term safety and tolerability of ianalumab in participants with systemic lupus erythematosus who have previously completed the treatment period in one of the two SIRIUS-SLE core studies (CVAY736F12301 or CVAY736F12302).
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Scientists map immune battlefield in chronic GVHD tissue
Knowledge-focused Recruiting nowGraft versus Host Disease (GVHD) is frequent after allogeneic stem cell transplantation (alloSCT). GVHD occurs following 2 patterns : acute GVHD (aGVHD) or chronic GVHD (cGVHD). The latter occurs in nearly 50% of patients and its pathogenesis remains poorly understood. Previous t…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThe purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors. The study is conducted in two parts - phase Ia (dose-escalation, dose-optimization) and phase Ib (dose-expansion). The study wi…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Antibiotic shots around wounds could speed healing in new trial
Disease control Recruiting nowChronic non-healing wounds are becoming an increasingly more common problem. Eligible, consenting patients with chronic wounds in the lower extremities, upper extremities or trunk, will either continue to the standard of care or will be randomized to the treatment cohort where an…
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Dye test may predict dangerous pancreatic leaks after surgery
Knowledge-focused Recruiting nowThis study evaluates the use of indocyanine green to predict postoperative pancreatic leaks in patients undergoing transection of the pancreas.
Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC